- CEO
- Liang Jin
- Full Time Employees
- 5,018
- Sector
- Health services
- Industry
- Hospital/Nursing management
- Address
- Shanghai China
- IPO Date
- Jul 5, 2022
- Business
- Bright Eye Hospital Group Co., Ltd. is a China-based healthcare provider specializing in the provision of comprehensive ophthalmic medical services and optical products. Founded in 2005 and headquartered in Chengdu, Sichuan Province, China, the company operates a nationwide chain of specialized eye hospitals and outpatient clinics across major metropolitan markets, including Beijing, Shanghai, Guangzhou, Shenzhen, Chengdu, Wuhan, Kunming, Lanzhou, Hefei, Zhengzhou, and Xi'an. The company organizes its core clinical operations across several specialized departments and service lines: refractive surgery services, featuring laser-assisted and lens-based vision correction procedures such as small incision lenticule extraction (SMILE and SMILE Pro), femtosecond laser-assisted in situ keratomileusis (FS-LASIK), transepithelial photorefractive keratectomy (TransPRK), and implantable collamer lens (ICL and TICL) surgeries; cataract diagnostic and surgical treatments, encompassing ultrasonic phacoemulsification, femtosecond laser-assisted cataract surgery, and premium intraocular lens (IOL) implantations including multifocal, toric, and extended depth of focus lenses; optometry and pediatric ophthalmology services, providing comprehensive medical optometric evaluations, amblyopia and strabismus therapies, vision training, and the dispensing of corrective spectacles, soft contact lenses, and orthokeratology (OK) lenses for juvenile myopia management; fundus and vitreoretinal care, involving vitrectomy, retinal laser photocoagulation, and anti-VEGF intraocular injections for diabetic retinopathy, retinal detachment, and age-related macular degeneration; ocular surface and corneal disease treatments, including corneal transplantation, keratoplasty, pterygium excision, and specialized dry eye therapies; glaucoma management, offering diagnostic tracking, medical management, laser iridotomy, and trabeculectomy; and oculoplastic, orbital, and lacrimal duct surgeries. Beyond direct clinical care, the group engages in hospital management, clinical ophthalmic research, ophthalmic medical device and instrument trading, and optical retail operations. In recent corporate developments, the company changed its legal name from Chengdu Bright Eye Hospital Group Co., Ltd. to Bright Eye Hospital Group Co., Ltd. in June 2025 to reflect its nationwide footprint and corporate scale. The company has continued its strategic capacity expansion by establishing and opening new medical centers across key provincial capitals and tier-one cities—including new facilities in Guangzhou, Shenzhen, Shanghai, Kunming, and Fuzhou—along with allocating capital toward the development of the Chengdu Jinjiang Bright Eye Hospital and the establishment of Chengdu Xingyao Bright Eye Hospital. The group has also pursued strategic diversification into adjacent healthcare and supply chain segments through investments in medical aesthetics via Qingdao Luxi Medical Beauty and medical apparatus distribution through Nantong Youci Medical Devices. Operationally, the company entered a strategic partnership with ByteDance's Feishu platform to build an integrated digital smart healthcare platform to streamline hospital administration, clinical workflows, and patient management, while concurrently deploying next-generation surgical equipment including SMILE Pro laser systems across its surgical suites. In corporate governance, the company appointed Wen Gao as General Manager in July 2026 to lead operational optimization and ongoing clinical network development.